News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

Nov 26, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents to Host Second CytoSorb® Users Meeting and Symposium at the DIVI Critical Care Congress

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy  company commercializing its CytoSorb® cytokine adsorber to...

Nov 21, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents Wins Beacon of Light Award

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb®...

Nov 14, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents Announces Appointment of New Board Director

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Nov 12, 2014, 16:14 ET
CytoSorbents Logo.

CytoSorbents Achieves First $1M in Quarterly CytoSorb Sales in Q3 2014

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Nov 10, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Announces Initial Partnership with a Leading Global Cardiac Surgery Company

 CytoSorbents Corporation (OTCQB: CTSO), a blood purification company commercializing its CE Mark approved CytoSorb® extracorporeal...

Nov 06, 2014, 17:09 ET
CytoSorbents Logo

CytoSorbents Issues Shareholder Update Letter on Consent Solicitation Statement and Up-Listing Plans

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood...

Nov 05, 2014, 08:05 ET
CytoSorbents Logo

CytoSorbents to Report Q3 2014 Operating and Financial Results

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood...

Nov 03, 2014, 08:30 ET

Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorb® to Treat SIRS and Cardiac Surgery Patients

 Biocon Ltd (BSE code: 532523, NSE: BIOCON),  Asia's premier biopharmaceuticals company, and U.S.-based CytoSorbents Corporation (OTCQB:...

Oct 14, 2014, 06:45 ET
CytoSorbents Logo

Preliminary Q3 2014 Report: CytoSorbents Achieves Its First Quarter of Approximately $1M in CytoSorb® Sales and Provides Up-listing Update

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood...

Oct 10, 2014, 06:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Wins 2014 GREAT Tech Award In Health

CytoSorbents Corporation (OTCQB: CTSO) is proud to announce that it was named the Health sector winner at the 2014 GREAT Tech Awards Gala last...

Oct 03, 2014, 07:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Launches International CytoSorb® Treatment Registry

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening conditions,...

Sep 18, 2014, 07:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Proudly Sponsors World Sepsis Day 2014, Celebration of Sepsis Heroes, and the Roger Bone Award

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using its CytoSorb® blood purification technology to treat...

Sep 09, 2014, 08:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Announces U.S. Cardiac Surgery Advisory Board

 CytoSorbents Corporation (OTCQB: CTSO), a blood purification company using its CytoSorb® extracorporeal cytokine adsorber to prevent or...

Sep 05, 2014, 08:50 ET
Joseph Rubin (PRNewsFoto/CytoSorbents Corporation)

In Memoriam: Joseph Rubin (1938-2014) - CytoSorbents Co-founder and Board Director

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company, remembers the significant contributions of its co-founder and...

Sep 03, 2014, 09:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents to Present at the 2014 Rodman & Renshaw Annual Global Investment Conference

 CytoSorbents Corporation (OTCQB: CTSO) announced that Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present at the Rodman &...

Aug 12, 2014, 16:05 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Records Another Solid Quarter of Growth in Q2 2014

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Aug 06, 2014, 09:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents to Report Q2 2014 Operating and Financial Results

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood...

Aug 05, 2014, 06:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Expands Distribution to Taiwan with Hemoscien Corporation

CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses,...

Jul 17, 2014, 06:00 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

First Publication Using CytoSorb® Therapy During Cardiac Surgery

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber in multiple...

Jul 09, 2014, 08:30 ET
CytoSorbents Logo.  (PRNewsFoto/CytoSorbents)

CytoSorbents Consolidates SEC and International Legal Counsel with DLA Piper

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses,...